-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How Can We Improve on the Already Impressive Results in Pediatric Acute Lymphocytic Leukemia?

Program: Education Program
Session: Novel Approaches to Acute Lymphoblastic Leukemia
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Tangerine 3 (WF3-4), Level 2 (Orange County Convention Center)
Saturday, December 5, 2015, 4:00 PM-5:30 PM
Tangerine 2 (WF2), Level 2 (Orange County Convention Center)

Angela E. Thomas, MBBS, PhD, FRCPE, FRCPath, FRCPCH

Royal Hospital for Sick Children, Edinburgh, United Kingdom

Disclosures: Off Label Use: The use of ruxolitinib, dasatinib and imatinib in Ph-like ALL will be discussed.

See more of: Novel Approaches to Acute Lymphoblastic Leukemia
See more of: Education Program
<< Previous Presentation | Next Presentation